RESOVIST 0.5mmol Fe / ml injectible solution medication leaflet

V08CB03 ferucarbotran • Various | Magnetic resonance imaging contrast media | Superparamagnetic contrast media


Ferucarbotran is an iron-based contrast agent used in magnetic resonance imaging (MRI), especially for evaluating the liver and spleen. This medication helps obtain clearer images, making it easier to diagnose certain liver or tumor conditions.

Ferucarbotran is administered by intravenous injection under medical supervision. The dose is determined by the doctor based on the patient's weight and needs. It is important to inform your doctor about any allergies or health problems before administration.

Common side effects include reactions at the injection site, nausea, headache, or temporary changes in taste. In rare cases, severe allergic reactions or breathing difficulties may occur. If you experience any unusual symptoms, contact medical staff immediately.

Ferucarbotran is a valuable tool for the accurate diagnosis of liver conditions, but its use requires careful medical supervision. Always inform your doctor about any other treatments or existing health conditions.

General data about RESOVIST 0.5mmol Fe / ml

Substance: ferucarbotran

Date of last drug list: 01-07-2013

Commercial code: W53399003

Concentration: 0.5mmol Fe / ml

Pharmaceutical form: injectible solution

Quantity: 10

Product type: original

Prescription restrictions: S - Medicines prescription reserved for use in certain specialized fields.